439 related articles for article (PubMed ID: 25652563)
1. Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoprotein.
Megson IL; Treweeke AT; Shaw A; MacRury SM; Setford S; Frias JP; Anhalt H
J Diabetes Sci Technol; 2015 May; 9(3):573-80. PubMed ID: 25652563
[TBL] [Abstract][Full Text] [Related]
2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
3. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
7. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
[TBL] [Abstract][Full Text] [Related]
8. Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction.
Chlup R; Runzis S; Castaneda J; Lee SW; Nguyen X; Cohen O
Diabetes Technol Ther; 2018 Feb; 20(2):153-159. PubMed ID: 29215299
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.
Pickup JC; Reznik Y; Sutton AJ
Diabetes Care; 2017 May; 40(5):715-722. PubMed ID: 28428322
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
12. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
[No Abstract] [Full Text] [Related]
13. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
[TBL] [Abstract][Full Text] [Related]
14. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
15. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
16. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
[TBL] [Abstract][Full Text] [Related]
17. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
18. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
Li LQ; Yao MY; Ma JX; Xue P; Li YK
Endocr J; 2019 Oct; 66(10):871-880. PubMed ID: 31243192
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.
Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L
J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]